NEWTON, Mass.--(BUSINESS WIRE)--Tryton Medical, Inc. has marked new milestones in stent technology by demonstrating on a global scale how the firm’s Side-Branch Stent offers unparalleled ease-of-use and the best option to safely and definitively treat bifurcation lesions. Tryton transmitted a live satellite feed of a successful clinical case to an audience of interventional cardiologists at TCT Asia 2007 in Seoul, Korea, performed by Robert van Geuns, M.D. Ph.D., Cardiologist, Thoraxcenter, Erasmus Medical Center. Professor Serruys, Head of the Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, moderated the event. Tryton’s Side-Branch Stent was also featured at the American College of Cardiology’s i2 Summit, where a live satellite feed of a clinical case, performed by Dr. George Sianos, Senior Interventionalist, Thoraxcenter, Erasmus Medical Center, was transmitted to demonstrate the ease-of-use and superb angiographic results that can be predictably achieved by using Tryton’s stent. The news follows a previous announcement that revealed the safety of Tryton’s stent during a live case that was performed in front of 1,000 interventional cardiologists at the Joint Interventional Meeting (JIM 2007) in Rome.
